Suppression of hyperventilation-induced attacks with infusion of atrial natriuretic peptide in patients with variant angina pectoris.
Atrial natriuretic peptide (ANP) is reported to dilate a major coronary artery in both experimental animals and humans. Spasm of a major coronary artery is the cause of variant angina pectoris and can be induced by hyperventilation. The effect of the ANP infusion on anginal attack induced by hyperventilation was studied in patients with variant angina pectoris. The study was performed in the early morning on 3 consecutive days in 11 patients with variant angina pectoris in whom the attacks were reproducibly induced by hyperventilation. On days 1 and 3 (saline solution infusion), and day 2 (ANP infusion), hyperventilation was started 14 minutes after beginning infusion of ANP (0.1 microgram/kg/min) or saline solution for 6 minutes. The attacks were induced in all 11 patients by hyperventilation on days 1 and 3. However, the attacks were not induced in any patient on day 2 of the ANP infusion. The plasma ANP level increased from 33 +/- 7 pg/ml to the peak level of 2,973 +/- 479 pg/ml (p < 0.01) at the end of the ANP infusion, and the plasma level of cyclic guanosine monophosphate (cGMP) increased from 5 +/- 1 pmol/ml to the peak level of 58 +/- 6 pmol/ml (p < 0.01) 5 minutes after the ANP infusion. The plasma levels of ANP and cGMP did not change after hyperventilation on days 1 and 3. It is concluded that the ANP infusion suppresses the attacks induced by hyperventilation in patients with variant angina pectoris, and cGMP is related to the mechanisms of suppression of the attacks.
Tanaka
H
H
Division of Cardiology, Kumamoto University School of Medicine, Japan.
Yasue
H
H
Yoshimura
M
M
Morita
E
E
Jougasaki
M
M
Kato
H
H
Miyao
Y
Y
Nakao
K
K
D000328:Adult; D000368:Aged; D000788:Angina Pectoris, Variant / Q000097:blood / Q000150:complications*; D009320:Atrial Natriuretic Factor / Q000008:administration & dosage* / Q000097:blood; D002245:Carbon Dioxide / Q000097:blood; D003329:Coronary Vasospasm / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D006152:Cyclic GMP / Q000097:blood; D004562:Electrocardiography / Q000187:drug effects; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006985:Hyperventilation / Q000097:blood / Q000150:complications / Q000517:prevention & control*; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D011863:Radioimmunoassay
D002245:Carbon Dioxide; D009320:Atrial Natriuretic Factor; D006152:Cyclic GMP; D010100:Oxygen